Treatment of Tardive Dyskinesia with Aripiprazole
✍ Scribed by Ricardo S. Osorio; L. Agüera-Ortiz; A. Hurtado de Mendoza; I. Ramos; T. Palomo
- Book ID
- 107678080
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 105 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1029-8428
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The objective of this report is to draw attention to tardive dyskinesia (TD) caused by aripiprazole, a third generation antipsychotic. TD has been traditionally attributed to typical (first‐generation) antipsychotics, but other dopamine receptor blocking drugs and atypical (second‐ and
Sixteen patients with tardive dyskinesia were treated with vitamin E in an open trial of on±o±on design. Abnormal involuntary movement scale (AIMS) ratings were performed in every phase of the study. The patients exhibited a signi®cant reduction in their mean AIMS score during vitamin E treatment. T
Two older female patients with a history of psychotic depression were treated with a combination of an antipsychotic and an antidepressant. Both developed persistent tardive dyskinesia with severe tongue protrusion. Botulinum toxin was injected into the genioglossal area and the embarrassing tongue